EUDAMED status update
Updates continue to be issued from the European Commission concerning EUDAMED in light of the current COVID-19 pandemic. The latest information sets new expectations about the availability of modules and expected activity.

EUDAMED is the European Databank on Medical Devices which came into force in May 2011. EUDAMED was created as a central repository for information on market surveillance exchanged between national competent authorities and the European Commission, with the purpose of strengthening surveillance and transparency with regards to medical devices placed on the European market.

The new regulations on medical devices (MDR) and on in vitro diagnostic medical devices (IVDR) establish a much wider EUDAMED database than the existing one under the current European Directives.

Updates continue to be issued from the European Commission concerning EUDAMED in light of the current COVID-19 pandemic.

The EUDAMED launch has been postponed with a two-year delay compared to initial expectation, until May 2022. However, the European Commission has announced that some modules of EUDAMED will be made available to users before the official EUDAMED date of application in May 2022. Hence, it becomes possible for economic operators to start using EUDAMED before May 2022.

At present, the European Commission has the following implementation plan:

2021 March: the Actor Registration Module will become available. This module will allow for manufacturers, authorized representatives, importers as well as systems and procedure pack producers to enter their data in EUDAMED and to acquire a Single Registration Number (SRN) for declarations of conformity and certificates.

2021 May (expected): the UDI/Device Registration Module and the Certificates and Notified Bodies Modules will be made available (after the Actor module, as soon as functional). At this time, it is anticipated that manufacturers will be able to begin submitting UDI information to EUDAMED.

2022 May: EUDAMED Launch (all modules complete and released, e.g., clinical investigations, incident reporting and market surveillance will become available afterwards as soon as they are functional).

2022 May – 2023 Nov: EUDAMED Device Registration period of 18 months for Legacy, MDR, and IVDR devices.

References:

1. European Commission – European database on medical devices (EUDAMED) – https://ec.europa.eu/growth/sectors/medical-devices/new-regulations/eudamed_en

further
reading

cosmetic products

P-Cymene may soon be banned from cosmetics

Ingredient: P-CYMENE

Date of publication: 10/1/2025

P-cymene may be banned from cosmetics as its proposed classification as Reprotoxic 1B is under review and is expected to be approved.

Read More »
cosmetic products

SCCS Preliminary Opinion on Benzophenone-1 (BP-1)

Ingredient: BENZOPHENONE-1

Date of publication: 25/10/2024

On October 25 2024, the Scientific Committee on Consumer Safety (SCCS) could not conclude on the safety of UV absorber Benzophenone-1 (BP-1) due to insufficient data. The deadline for comments is set to January 13, 2025.

Read More »
cosmetic products

UK – OPSS Releases Statuatory Instrument on CMR Substances and Kojic Acid

Ingredients: CMR SUBSTANCES AND KOJIC ACID

Date of publication: 17/12/2024

On December 17, 2024, UK’s Office for Product Safety and Standards (OPSS) published the Cosmetic Products (Restriction of Chemical Substances) (No.2) Regulations 2024′ adding 64 substances classified as Carcinogenic, Mutagenic, or Reprotoxic (CMR) to Annex II of the UK Cosmetics Regulation (UKCR) and Kojic Acid to Annex III of the UKCR.

Read More »
cosmetic products

SCCS Preliminary Opinion on Ethylhexyl Methoxycinnamate (EHMC)

Ingredient: ETHYLHEXYL METHOXYCINNAMATE (EHMC)

Date of publication: 25/10/2024

On October 25 2024, the Scientific Committee on Consumer Safety (SCCS) could not conclude on the safety of UV-filter Ethylhexyl Methocycinnamate (EHMC) due to insufficient data. The deadline for comments is set to January 17, 2025.

Read More »